A carregar...
Rapid Onset of Inflammatory Bowel Disease after Receiving Secukinumab Infusion
Secukinumab, an interleukin (IL)-17A antagonist, was associated with disease exacerbations in Crohn’s disease, and de novo cases of inflammatory bowel disease (IBD) have been reported in studies of rheumatoid diseases. However, there has been no detailed report demonstrating the linkage between secu...
Na minha lista:
| Publicado no: | ACG Case Rep J |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American College of Gastroenterology
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6072803/ https://ncbi.nlm.nih.gov/pubmed/30105273 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14309/crj.2018.56 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|